| Size & multiples | |||
| Market Cap | $4.51B | Enterprise Value | $4.26B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 3.15× | P/FCF | 28.00× |
| EV/EBITDA | 17.69× | EV/EBIT | 22.15× |
| EV/Sales | 2.97× | EV/FCF | 26.44× |
| FCF Yield | 3.57% | Buyback Yield | — |
| Owner Earnings (TTM) | $107.1M | Owner Earnings Yield | 2.38% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.85 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 8.24% |
| After-tax Cost of Debt | — | Synthetic credit rating | A- |
| Cost of Debt · embedded (pre-tax) | 14.70% | Cost of Debt · marginal (synthetic) | 4.89% |
| WACC | — | ROIC | 12.81% |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$4.45 · revenue TTM $1.43B · FCF TTM $161.0M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | 3.8% | -7.8% | -34.7%–1.4% | 83 ↑strong |
| Net Margin | -17.5% | -21.2% | -325.3%–7.2% | 52 ↑strong |
| Operating Margin | 14.4% | -34.5% | -552.0%–8.0% | 84 ↑strong |
| ROE | -19.2% | -36.8% | -92.5%–4.5% | 60 ↑strong |
